Connected Technology Solutions Dramatically Improve Medication Adherence

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA) has announced new study results demonstrating the use of a connected medication dispensing technology can greatly benefit patients with chronic conditions, helping them better comply with long-term therapy. Over the span of one year, user data from more than 1,300 patients in the Netherlands was analyzed, showing 96% of patients using Philips Medido, a connected medication dispensing solution, were adherent to their medication schedule. Data from the study also showed that patients using Medido stayed adherent to long-term therapy over time, showing little or no change in adherence over the course of the year.

Successful treatment with prescription medication requires consistent use over time. Studies have shown that during the treatment of chronic illnesses approximately 50% of patients do not adhere to their physician's long-term therapy recommendations [1, 2] While patients rely on their medications to keep them healthy and help them manage chronic conditions, complex medication schedules can often lead to mistakes, such as missed doses, incorrect amounts, or taking medications at the wrong time. Through a connected medication dispensing solution like Medido, patients living with chronic conditions can better manage their medication schedules, resulting in higher medication adherence and reduced costs of care.

"Proper medication adherence is such a crucial part to managing a chronic illness, and yet the more complicated a patient's care plan, the harder it can be to keep track of pills, doses, and the times they need to take their medication," said Kimberly O'Loughlin, Senior Vice President and General Manager of Home Monitoring, Philips. "By providing patients and caregivers with a solution that simplifies this part of the care process, they’re able to feel more independent and secure in their care, and feel more confident aging in the comfort of their own homes."

The study looked into 881,000 medication moments of 1,379 patients in the Netherlands who on average took three doses per day. Key data and findings from the study include:

  • 96% of patients using Medido had a medication adherence rate over the World Health Organization's (WHO) standard of 80%.
  • Patients who required two or more medication doses per day maintained an adherence rate at around 94% with Medido.
  • Medication adherence remained consistent over time, with no significant differences during the yearlong study.

In addition to improving medication adherence, connected technology solutions can have a significant economic impact. Earlier study findings conclude that an estimated costs saving of up to 40% per patient could be achieved for specific groups of patients when connected dispensing solutions are part of the patient's regimen [3].

Philips Medido is an innovative home medication dispensing service designed to support chronically ill patients and care providers. When the patient's scheduled medication time arrives, the dispenser automatically reminds them, ensures that the correct medication is being released at the correct time and then releases and opens individual pouches according to the patient's prescribed regimen. The solution monitors removing medication from the dispenser and remotely alerts nursing staff when medication is not taken from the device, helping to streamline the normally time-consuming task of medication management and allowing them to focus on additional care issues.

Medido is currently available in the Netherlands, with additional launches expected in the U.S. and Europe later this year. For more than 40 years, Philips has been a leader in connected home health solutions with its Lifeline business, helping seniors live more safely and independently. Last year, Philips launched CareSage, a predictive analytics engine that helps care providers remotely manage at-risk patients and predicts whether a patient will need emergency transport in the next 30 days.

Philips will also be showcasing its latest connected health software, solutions and services at eHealth Week 2016 in Amsterdam. For more information on Philips presence at eHealthWeek, please visit: www.philips.nl/ehealthweek.

1. Sabaté E, et al. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization 2003.
2. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proceedings 2011; 86 (4): 304-314.
3. Based on calculations for a patient receiving two combined-care visits and one medication-assistance-only visit a day in the Dutch context. This calculation was not part of the adherence data study. More info link to white paper

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 105,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...